• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The North America travel vaccines market reached a value of US$ 2.4 Billion in 2018. Vaccines are defined as biological preparations that protect the human body against severe and potentially deadly diseases. They generally consist of an agent made from the surface protein, toxins, weakened or killed forms of the disease-causing microorganisms. Vaccination enables the body to produce antibodies, which provide a shield in case the person is exposed to the disease. For travel vaccines, also known as travel immunizations, travelers are vaccinated 4 to 6 weeks before the journey. These can be differentiated between recommended and required vaccines. Wherein, required vaccines are essential for the individual to get before entering a country. However, recommended vaccines are those which the traveler may need because of a potential infection threat in the country or a part of that country. Some of the most common vaccine-preventable, travel-related diseases include influenza, meningitis, rabies, tick-borne encephalitis, polio, diphtheria, tetanus, pertussis, etc.

North America Travel Vaccines Market

North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease. As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc. Looking forward, IMARC Group expects the market to reach a value of US$ 3.3 Billion by 2024, registering a CAGR of 5.3% during 2019-2024.


Report Scope:

  • North America Travel Vaccines Market
     
  • Key Regions Analysed
    • United States
    • Canada
    • Mexico
       
  • Analysis for Each Country
     
  • Market by Composition
    • Mono Vaccines
    • Combination Vaccines
       
  • Market by Disease
    • Hepatitis A
    • DPT
    • Yellow Fever
    • Typhoid
    • Hepatitis B
    • Measles and Mumps
    • Rabies
    • Meningococcal
    • Varicella
    • Japanese Encephalitis
    • Others
       
  • Value Chain Analysis
  • Key Drivers and Challenges
  • Porters Five Forces Analysis
  • PESTEL Analysis
  • Government Regulations
  • Competitive Landscape
    • Competitive Structure
    • Key Player Profiles


Key Questions Answered in This Report:

  • How has the North America travel vaccines market performed so far and how will it perform in the coming years?
  • What are the key regions in the North America travel vaccines market?
  • What is the breakup of the North America travel vaccines market on the basis of composition?
  • What is the breakup of the North America travel vaccines market on the basis of disease?
  • What are the various stages in the value chain of the North America travel vaccines industry?
  • What are the key driving factors and challenges in the North America travel vaccines industry?
  • What is the structure of the North America travel vaccines industry and who are the key players?
  • What is the degree of competition in the North America travel vaccines industry?
  • What are the profit margins in the North America travel vaccines industry?


Report Coverage:

  • Base Year Considered: 2018
  • Historical Data Coverage: 2013-2018
  • Market Forecast: 2019-2024
  • Currency: US$
  • Geography Covered: North America, United States, Canada and Mexico
  • Segments Covered: Composition and Disease.


Report Customization: Although IMARC has tried to cover everything in the North America travel vaccines market landscape, we believe that every stakeholder may have their own specific needs. In view of this, we provide up to 20-man hours of free customization for each report.

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Travel Vaccines Market
    5.1    Market Performance
    5.2    Market Breakup by Composition
    5.3    Market Breakup by Disease
    5.4    Market Breakup by Region 
    5.5    Market Forecast 
6    North America Travel Vaccines Market
    6.1    Market Performance
    6.2    Market Forecast 
7    North America Travel Vaccines Market: Breakup by Composition
    7.1    Mono Vaccines
    7.2    Combination Vaccines
8    North America Travel Vaccines Market: Breakup by Disease
    8.1    Hepatitis A
    8.2    DPT
    8.3    Yellow Fever
    8.4    Typhoid
    8.5    Hepatitis B
    8.6    Measles and Mumps
    8.7    Rabies
    8.8    Meningococcal
    8.9    Varicella
    8.10    Japanese Encephalitis
    8.11    Others
9    North America Travel Vaccines Market: Breakup by Country 
    9.1   United States
     9.1.1    Historical market Trends
     9.1.2    Market Breakup by Composition
     9.1.3    Market Breakup by Disease
     9.1.4    Market Forecast
    9.2   Canada
     9.2.1    Historical market Trends
     9.2.2    Market Breakup by Composition 
     9.2.3    Market Breakup by Disease
     9.2.4    Market Forecast
    9.3   Mexico
     9.3.1    Historical market Trends
     9.3.2    Market Breakup by Composition 
     9.3.3    Market Breakup by Disease
     9.3.4    Market Forecast
10    SWOT Analysis 
    10.1    Overview 
    10.2    Strengths
    10.3    Weaknesses 
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis 
    11.1     Overview
    11.2     Exploratory Stage
    11.3     Preclinical and Clinical Development
    11.4     Regulatory Approval
    11.5     Manufacturing
    11.6     Marketing and Distribution
12    Porter’s Five Forces Analysis 
    12.1     Overview
    12.2     Bargaining Power of Buyers
    12.3     Bargaining Power of Suppliers
    12.4     Degree of Rivalry
    12.5     Threat of New Entrants
    12.6     Threat of Substitutes
13    Price Analysis 
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players

List of Figures

Figure 1: Global: Travel Vaccines Market: Value Trends (in Billion US$), 2013-2018
Figure 2: Global: Travel Vaccines Market: Breakup by Composition (in %), 2018
Figure 3: Global: Travel Vaccines Market: Breakup by Disease (in %), 2018
Figure 4: Global: Travel Vaccines Market: Breakup by Region (in %), 2018
Figure 5: Global: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2019-2024
Figure 6: North America: Travel Vaccines Market: Value Trends (in Billion US$), 2013-2018
Figure 7: North America: Travel Vaccines Market Forecast: Value Trends (in Billion US$), 2019-2024
Figure 8: North America: Travel Vaccines Market: Breakup by Composition (in %), 2018
Figure 9: North America: Travel Vaccines (Mono Vaccines) Market: Value Trends (in Million US$), 2013 & 2018
Figure 10: North America: Travel Vaccines (Mono Vaccines) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 11: North America: Travel Vaccines (Combination Vaccines) Market: Value Trends (in Million US$), 2013 & 2018
Figure 12: North America: Travel Vaccines (Combination Vaccines) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 13: North America: Travel Vaccines Market: Breakup by Disease (in %), 2018
Figure 14: North America: Travel Vaccines (Hepatitis A) Market: Value Trends (in Million US$), 2013 & 2018
Figure 15: North America: Travel Vaccines (Hepatitis A) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 16: North America: Travel Vaccines (DPT) Market: Value Trends (in Million US$), 2013 & 2018
Figure 17: North America: Travel Vaccines (DPT) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 18: North America: Travel Vaccines (Yellow Fever) Market: Value Trends (in Million US$), 2013 & 2018
Figure 19: North America: Travel Vaccines (Yellow Fever) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 20: North America: Travel Vaccines (Typhoid) Market: Value Trends (in Million US$), 2013 & 2018
Figure 21: North America: Travel Vaccines (Typhoid) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 22: North America: Travel Vaccines (Hepatitis B) Market: Value Trends (in Million US$), 2013 & 2018
Figure 23: North America: Travel Vaccines (Hepatitis B) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 24: North America: Travel Vaccines (Measles and Mumps) Market: Value Trends (in Million US$), 2013 & 2018
Figure 25: North America: Travel Vaccines (Measles and Mumps) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 26: North America: Travel Vaccines (Rabies) Market: Value Trends (in Million US$), 2013 & 2018
Figure 27: North America: Travel Vaccines (Rabies) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 28: North America: Travel Vaccines (Meningococcal) Market: Value Trends (in Million US$), 2013 & 2018
Figure 29: North America: Travel Vaccines (Meningococcal) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 30: North America: Travel Vaccines (Varicella) Market: Value Trends (in Million US$), 2013 & 2018
Figure 31: North America: Travel Vaccines (Varicella) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 32: North America: Travel Vaccines (Japanese Encephalitis) Market: Value Trends (in Million US$), 2013 & 2018
Figure 33: North America: Travel Vaccines (Japanese Encephalitis) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 34: North America: Travel Vaccines (Other Compositions) Market: Value Trends (in Million US$), 2013 & 2018
Figure 35: North America: Travel Vaccines (Other Compositions) Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 36: North America: Travel Vaccines Market: Breakup by Country (in %), 2018
Figure 37: United States: Travel Vaccines Market: Value Trends (in Million US$), 2013-2018
Figure 38: United States: Travel Vaccines Market: Breakup by Composition (in %), 2018
Figure 39: United States: Travel Vaccines Market: Breakup by Disease (in %), 2018
Figure 40: United States: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 41: Canada: Travel Vaccines Market: Value Trends (in Million US$), 2013-2018
Figure 42: Canada: Travel Vaccines Market: Breakup by Composition (in %), 2018
Figure 43: Canada: Travel Vaccines Market: Breakup by Disease (in %), 2018
Figure 44: Canada: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 45: Mexico: Travel Vaccines Market: Value Trends (in Million US$), 2013-2018
Figure 46: Mexico: Travel Vaccines Market: Breakup by Composition (in %), 2018
Figure 47: Mexico: Travel Vaccines Market: Breakup by Disease (in %), 2018
Figure 48: Mexico: Travel Vaccines Market Forecast: Value Trends (in Million US$), 2019-2024
Figure 49: North America: Travel Vaccines Industry: SWOT Analysis
Figure 50: North America: Travel Vaccines Industry: Value Chain Analysis
Figure 51: North America: Travel Vaccines Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: Travel Vaccines Market: Key Industry Highlights, 2018 and 2024
Table 2: North America: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2019-2024
Table 3: North America: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2019-2024
Table 4: North America: Travel Vaccines Market Forecast: Breakup by Country (in Million US$), 2019-2024
Table 5: North America: Travel Vaccines Market: Competitive Structure
Table 6: North America: Travel Vaccines Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links